BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic trial of paromomycin sulfate in intestinal amebiasis]. 1960

J RUILOBA, and G DE ESESARTE, and A PARDO

UI MeSH Term Description Entries
D010303 Paromomycin An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D004404 Dysentery, Amebic DYSENTERY caused by intestinal amebic infection, chiefly with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the LIVER and other distant sites. Amebiasis, Intestinal,Amebic Dysentery,Colitis, Amebic,Entamoebiasis, Intestinal,Intestinal Amebiasis,Amoebiasis, Intestinal,Amoebic Colitis,Amoebic Dysentery,Intestinal Amoebiasis,Intestinal Entamoeba histolytica Infection,Amebiases, Intestinal,Amebic Colitides,Amebic Colitis,Amebic Dysenteries,Amoebiases, Intestinal,Amoebic Colitides,Amoebic Dysenteries,Colitides, Amebic,Colitides, Amoebic,Colitis, Amoebic,Dysenteries, Amebic,Dysenteries, Amoebic,Dysentery, Amoebic,Entamoebiases, Intestinal,Intestinal Amebiases,Intestinal Amoebiases,Intestinal Entamoebiases,Intestinal Entamoebiasis
D000562 Amebiasis Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur. Abscess, Amebic,Acanthamebiasis,Ameboma,Amoebiasis,Iodamoebiasis,Acanthamoeba Infection,Balamuthia Infection,Abscesses, Amebic,Acanthamebiases,Acanthamoeba Infections,Amebiases,Amebic Abscess,Amebic Abscesses,Amoebiases,Balamuthia Infections,Infection, Acanthamoeba,Infection, Balamuthia,Iodamoebiases
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

J RUILOBA, and G DE ESESARTE, and A PARDO
[TREATMENT OF INTESTINAL AMEBIASIS WITH PAROMOMYCIN SULFATE].
January 1963, Medecine tropicale : revue du Corps de sante colonial,
J RUILOBA, and G DE ESESARTE, and A PARDO
[Treatment of intestinal amebiasis with paromomycin sulfate].
January 1961, Revista do Instituto de Medicina Tropical de Sao Paulo,
J RUILOBA, and G DE ESESARTE, and A PARDO
[TREATMENT OF INTESTINAL AMEBIASIS BY PAROMOMYCIN SULFATE].
March 1964, La Presse medicale,
J RUILOBA, and G DE ESESARTE, and A PARDO
[Treatment of chronic intestinal amebiasis with paromomycin sulfate (Humatin)].
January 1962, Boletin chileno de parasitologia,
J RUILOBA, and G DE ESESARTE, and A PARDO
[Treatment of intestinal amebiasis by a nonresorbable antibiotic: paromomycin sulfate].
March 1960, La Presse medicale,
J RUILOBA, and G DE ESESARTE, and A PARDO
[Treatment of intestinal amebiasis with a single dose of paromomycin sulfate].
January 1961, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
J RUILOBA, and G DE ESESARTE, and A PARDO
TREATMENT OF INTESTINAL AMEBIASIS WITH PAROMOMYCIN.
June 1964, The American journal of digestive diseases,
J RUILOBA, and G DE ESESARTE, and A PARDO
[Intestinal amebiasis; diagnostic significance of biopsy and therapeutic results with paromomycin].
February 1961, Ceskoslovenska gynekologie,
J RUILOBA, and G DE ESESARTE, and A PARDO
Paromomycin in the treatment of intestinal amebiasis.
November 1960, Antibiotic medicine & clinical therapy (New York, NY),
J RUILOBA, and G DE ESESARTE, and A PARDO
Paromomycin as a therapeutic substance for intestinal amebiasis and bacterial enteritis.
January 1959, Antibiotics annual,
Copied contents to your clipboard!